Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Electron, Bruker Daltonics, Gary Blackburn, Nicholas Cozzarelli, Nicholas Ventresca


New Products

Thermo Electron announced last week the expansion of its HeavyPeptide AQUA product line. The HeavyPeptide AQUA kits can now be prepared with covalent modifications, such as phosphorylation, which are chemically identical to naturally occurring post-translational modifications.

Phosphorylation modification is now also available on Thermo's HeavyPeptide BASIC platform for high-throughput, pre-quantitative screening, and relative quantification.

Bruker Daltonics launched this week its Clinprot Forum — an online forum moderated by Bruker application scientists that is available for all Bruker Daltonics customers at

The discussion forum covers various aspects of clinical proteomics, such as biofluid profiling and validation, biomarker identification, the MALDI Molecular Imager, and the MALDI BioTyper for microorganism identification. It is designed to facilitate efficient information exchange and to stimulate the formation of research collaborations between different laboratories, Bruker said. Discussion threads include topics like sample preparation, standardization, biomarker identification, and bioinformatics methods.


Movers & Shakers

Gary Blackburn has become president and chief executive officer of Ohmx, the Evanston, Ill.-based protein biosensor company said on Monday. Most recently, he was director of research and technology at Motorola Clinical Micro Sensors.

Nicholas Cozzarelli, editor in chief of PNAS and a professor of molecular and cell biology at the University of California, Berkeley, died on March 19 from complications of treatment for Burkitt's lymphoma. He was 67. Cozzarelli received an undergraduate degree in biology from Princeton University and a PhD in biochemistry from Harvard Medical School.

Nicholas Ventresca has become corporate senior vice president of information technology as well as chief information officer of Charles River Laboratories, the company said last week. Prior to joining Charles River Labs, Ventresca was vice president in business technology for Pfizer's corporate headquarters in New York and R&D headquarters in New London, Conn.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.